Rucaparib Extends PFS in Ovarian Cancer
Rucaparib Extends PFS in Ovarian Cancer
(February 3, 2017) Results from the ARIEL2 trial, funded in part by OCRFA’s grant to the Stand Up to Cancer Ovarian Cancer Dream Team, were recently published in The Lancet. … Continued